Relife Pharmaceuticals Opc Private Limited, Engaging in drug formulation & development within the trade sector, it holds CIN: U52100WB2016OPC209749. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹9.00 M and a paid-up capital of ₹5.00 M.
It upholds a compliant status. Employing 26 professional, Its leadership includes Santosh Kumar Shah (Director). Past directors included Anjana Shaw. It holds ₹5.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D3 64/230 Alampur Bye Lane - Ii, Belpukur Road Near Sitala Mandir, Kolkata, West Bengal, 700024.
U52100WB2016OPC209749
209749
16 February 2016
₹9.00 M
₹5.00 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Relife Pharmaceuticals Opc Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Santosh Kumar Shah | Director | 16 Feb 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Relife Pharmaceuticals Opc Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.49% increase. The company also saw a substantial improvement in profitability, with a 20.65% increase in profit. The company's net worth Soared by an impressive increase of 51.84%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Relife Pharmaceuticals Opc's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 May 2024 | Others | ₹2.50 Cr | Open |
| 28 Dec 2023 | Others | ₹2.50 Cr | Open |
Explore comprehensive loan charge details -
Relife Pharmaceuticals Opc has a workforce of 26 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Relife Pharmaceuticals Opc, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relife Pharmaceuticals Opc's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Relife Pharmaceuticals Opc Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
A charge with Others amounted to Rs. 25.00 M with Charge ID 100917101 was registered on 10 May 2024. was recorded as a recent event.
Progress on Relife Pharmaceuticals Opc Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was documented.
A charge with Others amounted to Rs. 25.00 M with Charge ID 100849182 was registered on 28 Dec 2023. was recorded as a recent event.
Santosh Kumar Shah was appointed as a Director was appointed as a Director on 16 Feb 2016 & has been associated with this company since 9 years 10 months . was recorded as a recent event.
Progress on Relife Pharmaceuticals Opc Private Limited was registered on 16 Feb 2016 with Roc Kolkata & aged 9 years 10 months as per MCA records. was documented.
The CIN of Relife Pharmaceuticals Opc Private Limited is U52100WB2016OPC209749.
Relife Pharmaceuticals Opc Private Limited is headquartered at D3 64/230 Alampur Bye Lane - Ii, Belpukur Road Near Sitala Mandir, Kolkata, West Bengal, 700024.
Relife Pharmaceuticals Opc Private Limited was incorporated on 16 February 2016.
The current directors of Relife Pharmaceuticals Opc Private Limited are
The primary industry of Relife Pharmaceuticals Opc Private Limited is Trade.
Relife Pharmaceuticals Opc Private Limited is unlisted.
The authorized capital of Relife Pharmaceuticals Opc Private Limited is ₹9.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Relife Pharmaceuticals Opc Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX